(Hypertension. 1995;26:796.)
© 1995 American Heart Association, Inc.
Articles |
Enhanced Levels of Tissue-Type Plasminogen Activator in Borderline Hypertension
From the Hypertension Section, Departments of Clinical Physiology (U.W., S.J.) and Internal Medicine (U.W., A.B., S.J.), Östra University Hospital, and Institute of Clinical Neuroscience (C.J.), Department of Neurology, Sahlgren’s University Hospital, University of Göteborg, Sweden.
Correspondence to Ulrika Wall, MD, Department of Medicine, Östra Hospital, S-416 85 Göteborg, Sweden.
Abstract Despite effective antihypertensive therapy, essential hypertension is still associated with considerable residual risk of cardiovascular complications. The aim of the present study was to investigate the state of the endogenous fibrinolytic system in young subjects with borderline hypertension. Thirty-nine young (age, 24 to 34 years) male subjects with borderline hypertension (systolic BP [SBP] 140 to 160 mm Hg and/or diastolic BP [DBP] 85 to 95 mm Hg) and 17 normotensive control subjects (age, 22 to 31 years; SBP 110 to 130 and DBP 60 to 80 mm Hg) were recruited from a population screening. Plasma levels of tissue-type plasminogen activator (t-PA) antigen and activity and plasminogen activator inhibitor 1 (PAI-1) antigen were determined at rest and in response to a venous occlusion test. Borderline-hypertensive subjects had metabolic and anthropometric characteristics similar to normotensive individuals. In comparison with normotensive subjects, borderline-hypertensive subjects had higher plasma concentration of t-PA antigen both at rest and after venous occlusion but similar levels of t-PA activity or PAI-1 antigen. The increase in t-PA antigen and activity in response to venous occlusion was significantly greater in borderline-hypertensive subjects than in normotensive control subjects (P<.0001 and P=.003, respectively). In stepwise regression analyses, 24-hour mean arterial pressure emerged as the single most powerful predictor of t-PA antigen levels, but body mass index was the most important determinant of t-PA activity and PAI-1 antigen. However, PAI-1 was explained by both body mass index (partial r=.48, P<.001) and 24-hour mean arterial pressure (partial r=.29, P<.05). Thus, early hypertension may be associated with significant alterations in endogenous fibrinolysis.
Key Words: hypertension, borderline • fibrinolysis • alteplase • plasminogen activator inhibitor 1
This article has been cited by other articles:
 |
|
 |
|
  T. J. Wang, P. Gona, M. G. Larson, D. Levy, E. J. Benjamin, G. H. Tofler, P. F. Jacques, J. B. Meigs, N. Rifai, J. Selhub, et al. Multiple Biomarkers and the Risk of Incident Hypertension Hypertension, March 1, 2007; 49(3): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwashima, T. Katsuya, K. Ishikawa, N. Ouchi, M. Ohishi, K. Sugimoto, Y. Fu, M. Motone, K. Yamamoto, A. Matsuo, et al. Hypoadiponectinemia Is an Independent Risk Factor for Hypertension Hypertension, June 1, 2004; 43(6): 1318 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Poli, G. H. Tofler, M. G. Larson, J. C. Evans, P. A. Sutherland, I. Lipinska, M. A. Mittleman, J. E. Muller, R. B. D’Agostino, P. W. F. Wilson, et al. Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population Circulation, January 25, 2000; 101(3): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dell'Omo, L. Ferrini, M. Morale, F. De Negri, E. Melillo, F. Carmassi, and R. Pedrinelli Acetylcholine-Mediated Vasodilatation and Tissue-type Plasminogen Activator Release in Normal and Hypertensive Men Angiology, April 1, 1999; 50(4): 273 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Jern, P. Ladenvall, U. Wall, and S. Jern Gene Polymorphism of t-PA is Associated With Forearm Vascular Release Rate of t-PA Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 454 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kristensen, J. Malm, T. K. Nilsson, J. Hultdin, B. Carlberg, and T. Olsson Increased Fibrinogen Levels and Acquired Hypofibrinolysis in Young Adults With Ischemic Stroke Stroke, November 1, 1998; 29(11): 2261 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jern, U. Wall, A. Bergbrant, L. Selin-Sjogren, and C. Jern Endothelium-Dependent Vasodilation and Tissue-Type Plasminogen Activator Release in Borderline Hypertension Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3376 - 3383. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. DeSouza, D. R. Dengel, M. A. Rogers, K. Cox, and R. F. Macko The Fibrinolytic System Is Not Impaired in Older Men With Hypertension Hypertension, May 1, 1996; 27(5): 1053 - 1058. [Abstract] [Full Text]
|
|